| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.031 | 33.348 | 37.260 | 37.532 | 37.154 | 28.845 | 39.496 | 41.727 | 52.195 | 59.263 |
| Total Income - EUR | 28.031 | 33.348 | 37.260 | 37.532 | 37.154 | 29.775 | 39.496 | 41.727 | 52.195 | 59.263 |
| Total Expenses - EUR | 9.326 | 11.208 | 20.752 | 23.865 | 28.274 | 25.374 | 32.350 | 37.033 | 48.158 | 55.218 |
| Gross Profit/Loss - EUR | 18.705 | 22.141 | 16.508 | 13.667 | 8.880 | 4.402 | 7.146 | 4.694 | 4.037 | 4.046 |
| Net Profit/Loss - EUR | 17.864 | 21.274 | 15.390 | 12.541 | 7.792 | 3.536 | 6.104 | 3.442 | 3.102 | 3.398 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Chr Consult Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 333 | 515 | 504 | 576 | 2.736 | 3.082 |
| Current Assets | 67.609 | 25.152 | 17.137 | 14.274 | 21.547 | 24.757 | 18.239 | 21.933 | 5.948 | 7.467 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 331 | 0 | 20 | 0 |
| Receivables | 35.265 | 25.116 | 2.251 | 13.901 | 20.871 | 21.406 | 17.908 | 18.295 | 1.723 | 1.714 |
| Cash | 32.344 | 36 | 14.886 | 373 | 676 | 3.351 | 0 | 3.638 | 4.206 | 5.754 |
| Shareholders Funds | 48.082 | 134 | 15.521 | 129 | 7.919 | 11.305 | 17.158 | 3.564 | 6.655 | 10.016 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 19.528 | 25.019 | 1.616 | 14.145 | 13.961 | 13.967 | 1.585 | 18.945 | 2.030 | 533 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Chr Consult Intermed S.r.l.